Skip to main content
. 2017 Jan 12;292(9):3666–3682. doi: 10.1074/jbc.M116.772723

FIGURE 7.

FIGURE 7.

Schematic presentation of the model of mutant CBL gain-of-function based on present studies. TKB, tyrosine kinase-binding domain; RF, RING finger domain; PRR, proline-rich region; CTR, C-terminal region; Ub, Ubiquitin; P, phosphorylation.